Researcher.Life Logo

Neuropsychiatric Disease and Treatment : Impact Factor & More

eISSN: 1178-2021pISSN: 1176-6328
JournalOpen Access

Key Metrics

CiteScore
4.5
Impact Factor
< 5
SJR
Q3Biological Psychiatry
SNIP
1.09
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Neuropsychiatric Disease and Treatment

Neuropsychiatric Disease and Treatment Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • DOAJ DOAJ
  • SJR SJR
Overview
Publisher DOVE MEDICAL PRESS LTD
Language English
Frequency Continuous publication
Article Processing ChargesUSD 2836
Publication Time16
Editorial Review ProcessAnonymous peer review
General Details
LanguageEnglish
FrequencyContinuous publication
Publication Start Year2005
Publisher URLVisit website
Website URLVisit website
Publication Details
PlagiarismVisit website
Publication Time 16
Waiver PolicyVisit website
Editorial Review Detail
Editorial TeamVisit website
Review ProcessAnonymous peer review
Review UrlVisit website
Information for authors
Author instructionsVisit website
Copyright DetailsVisit website
Deposit PolicySherpa/Romeo
License typeCC BY, CC BY-NC
OA statementVisit website
View less

Planning to publish in Neuropsychiatric Disease and Treatment ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Neuropsychiatric Disease and Treatment

The Influence of Lifestyle on Cognitive Function and Quality of Life in People with Dementia
  • 3 Apr 2026
  • Neuropsychiatric Disease and Treatment
Correlates of Anti-Toxoplasma IgG Antibodies in Females with Borderline Personality Disorder: A Pilot Cross-Sectional Study
  • 3 Apr 2026
  • Neuropsychiatric Disease and Treatment
Efficacy and Clinical Relevance of Adjunctive Cariprazine Treatment in Patients with Major Depressive Disorder: Post Hoc Analyses from a Phase III Study
  • 1 Apr 2026
  • Neuropsychiatric Disease and Treatment
Wavelet Entropy Analysis of EEG Signals During Wake and Sleep in Patients with Alzheimer’s Disease: A Pilot Study
  • 1 Apr 2026
  • Neuropsychiatric Disease and Treatment
Parallel Single-Tissue Summary-Data Mendelian Randomization and Functional Validation Identify the ARRDC1 Promoter SNP rs4494021 as a Genetic Marker Associated with Anxiety Disorders.
  • 1 Apr 2026
  • Neuropsychiatric disease and treatment
Clinical Efficacy of Integrated Acupuncture and Moxibustion Therapy Combined with Drugs in the Treatment of Acute Depressive Disorder: Protocol for a Pragmatic Randomized Controlled Trial
  • 1 Apr 2026
  • Neuropsychiatric Disease and Treatment
The Influence of Lifestyle on Cognitive Function and Quality of Life in People with Dementia
  • 3 Apr 2026
  • Neuropsychiatric Disease and Treatment
Correlates of Anti-Toxoplasma IgG Antibodies in Females with Borderline Personality Disorder: A Pilot Cross-Sectional Study
  • 3 Apr 2026
  • Neuropsychiatric Disease and Treatment
Efficacy and Clinical Relevance of Adjunctive Cariprazine Treatment in Patients with Major Depressive Disorder: Post Hoc Analyses from a Phase III Study
  • 1 Apr 2026
  • Neuropsychiatric Disease and Treatment
Wavelet Entropy Analysis of EEG Signals During Wake and Sleep in Patients with Alzheimer’s Disease: A Pilot Study
  • 1 Apr 2026
  • Neuropsychiatric Disease and Treatment
Parallel Single-Tissue Summary-Data Mendelian Randomization and Functional Validation Identify the ARRDC1 Promoter SNP rs4494021 as a Genetic Marker Associated with Anxiety Disorders.
  • 1 Apr 2026
  • Neuropsychiatric disease and treatment
Clinical Efficacy of Integrated Acupuncture and Moxibustion Therapy Combined with Drugs in the Treatment of Acute Depressive Disorder: Protocol for a Pragmatic Randomized Controlled Trial
  • 1 Apr 2026
  • Neuropsychiatric Disease and Treatment

FAQs on Neuropsychiatric Disease and Treatment